SCHEMBL6049335

SCHEMBL6049335

FC(F)(F)Cc1cccc(OCCC(Cl)I)c1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ GGPS1 O95749 2/20 0.38
▸ CETP P11597 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NR1H2 P55055 4/20 0.35
▸ NR1H3 Q13133 4/20 0.35
▸ KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6049352 0.86 KCNH2 (0.43) L3MBTL1MAPK1TSHRTDP1NR1H2
SCHEMBL6049355 0.86 MAPK1 (0.42) L3MBTL1MAPK1TSHRTDP1GGPS1
SCHEMBL6049377 0.82 MAPT (0.41) L3MBTL1CETPKDM4EALDH1A1LMNA
SCHEMBL6049337 0.82 L3MBTL1 (0.52) L3MBTL1KDM4EALDH1A1LMNAGAA
SCHEMBL6049333 0.76 CETP (0.38) L3MBTL1MAPK1TSHRTDP1CETP
SCHEMBL15561594 0.75 MAOB (0.40) GGPS1CETPKCNH2
SCHEMBL20273045 0.73 GRM2 (0.46) GGPS1KMT2A
SCHEMBL6687877 0.70 CETP (0.39) CETPKMT2A
SCHEMBL22827424 0.70 TAAR1 (0.55) ALDH1A1
SCHEMBL10545790 0.68 MAOB (0.50) TSHRTDP1CETPKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539136-A4 PPAR ALPHA SELECTIVE COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS MERCK & CO INC (US) 2006-10-18 — — EP disclosed
EP-1539136-A2 PPAR ALPHA SELECTIVE COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS Merck & Co., Inc. (US) 2005-06-15 — — EP disclosed
WO-2004010936-A2 PPAR ALPHA SELECTIVE COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS MERCK & CO., INC. (US) 2004-02-05 — — WO disclosed
Send feedback